alpha-conotoxin imi has been researched along with Breast Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, W; Fu, J; Gao, W; He, B; Lin, Z; Lu, W; Ma, L; Mei, D; Wang, J; Wang, X; Zhang, H; Zhang, Q; Zhang, X; Zhou, D | 1 |
1 other study(ies) available for alpha-conotoxin imi and Breast Neoplasms
| Article | Year |
|---|---|
The use of α-conotoxin ImI to actualize the targeted delivery of paclitaxel micelles to α7 nAChR-overexpressing breast cancer.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Apoptosis; Breast Neoplasms; Calcium; Cell Line, Tumor; Computer Systems; Conotoxins; Drug Delivery Systems; Female; Humans; Injections, Intravenous; Mice, Nude; Micelles; Nanomedicine; Paclitaxel; Phosphatidylethanolamines; Polyethylene Glycols; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Toxicity Tests; Treatment Outcome; Xenograft Model Antitumor Assays | 2015 |